Denmark· DK-28106749422
Tibsovo
A ivosidenib product containing ivosidenib, registered in Denmark by Les Laboratoires Servier. The same ATC class is registered in 11 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Ivosidenib is registered in 11 of 19 countries.
Countries holding a registration under ATC L01XM02 (ivosidenib), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Ivosidenib · ATC L01XM02
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Ivosidenib
- Manufacturer
- Les Laboratoires Servier
- Country
- Denmark (DK)
- ATC code
- L01XM02
- ATC class
- Ivosidenib
- Defined daily dose
- 0.5 g, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106749422
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
516 interactions on record for ivosidenib.
Graded by severity as the source publishes them — 278 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ivosidenib · interactions on record
516 records
- 278 severe
- 223 moderate
- 15 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under L01XM02
Ivosidenib, as other registers publish it.
- NorwayTibsovoLes Laboratoires Servier
- IcelandTibsovoLes Laboratoires Servier*
- PolandTibsovoLes Laboratoires Servier
- FinlandTibsovoLes Laboratoires Servier
- United StatesTIBSOVOServier Pharmaceutical LLC
- CzechiaTIBSOVOLes Laboratoires Servier, Suresnes cedex
- BelgiumTibsovo 250 mgLes Laboratoires Servier
- IrelandTibsovo 250 mg Film-coated tabletLes Laboratoires Servier
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d19fd57e-ac8f-4743-a29c-c1c31d5fe464 GET /v1/drugs/d19fd57e-ac8f-4743-a29c-c1c31d5fe464?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "250 mg",
"auth_role": "MOD",
"dk_drugid": "28106749422",
"substance": "Ivosidenib",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "45050"
}See everything about ivosidenib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.